Delivery Order SPE2DR25D6028-SPE2DR26FARSC
Award Date 11/14/25
Potential Completion Date 12/12/25
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Ondansetron ODT 8 mg tablets in a 30-count package. This is a firm fixed price delivery order with a ceiling value of $3,275.55 and an ultimate completion date of October 20, 2025. The contract was competitively awarded with no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $17,662.48 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count package) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitive, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 and extends through December 2026. The...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Ondansetron ODT (orally disintegrating tablet) 8mg in a quantity of 30 tablets, with a ceiling value of $6,070.84 and a firm fixed price structure. The delivery order, which is a child contract under a larger vehicle, has an ultimate completion date of October 20, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2024, for the supply of Ondansetron ODT 8 mg tablets (30 count) with a contract value of $17,810.92. This firm fixed-price delivery order, with an ultimate completion date of October 22, 2024, represents a non-competitive set-aside award supporting federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $4,930.33 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30, with an ultimate completion date of August 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a $11,073.06 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ondansetron HCl 4 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 10, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,566.42 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT (orally disintegrating tablet) 8 mg in quantities of 30 tablets. The contract is a firm fixed price delivery order with an ultimate completion date of September 19, 2025, and was awarded on September 18, 2025. This award carries no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to the Conshohocken,...
- The Defense Logistics Agency awarded a $2,731.96 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count units) on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed price contract represents a non-competitive set-aside order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed at the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a $8,059.34 delivery order to AmerisourceBergen Drug Corp on May 16, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30. The award is non-competitive and structured as a firm fixed price delivery order, with an ultimate completion date of May 19, 2025. Performance of this contract will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count units) with a ceiling value of $25,388.02. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken,...